Gene · 652995
Papers3,485
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
701 to 720 of 3,485
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Regulatory mechanisms and function of hypoxia-induced long noncoding RNA NDRG1-OT1 in breast cancer cells. | Cell Death Dis | 2022 | 36127332 | PubTator, text mining | PubMed |
| lncRNAs: Key Regulators of Signaling Pathways in Tumor Glycolysis. | Dis Markers | 2022 | 36124026 | PubTator, text mining | PubMed |
| Urinary exosomal long non-coding RNAs as noninvasive biomarkers for diagnosis of bladder cancer by RNA sequencing. | Front Oncol | 2022 | 36119544 | PubTator, text mining | PubMed |
| Current perspectives on clinical use of exosomes as novel biomarkers for cancer diagnosis. | Front Oncol | 2022 | 36119470 | PubTator, text mining | PubMed |
| MicroRNA-1306-5p Regulates the METTL14-Guided m6A Methylation to Repress Acute Myeloid Leukemia. | Comput Math Methods Med | 2022 | 36118827 | PubTator, text mining | PubMed |
| lncRNA UCA1 induces autophagic gene expression via epigenetic regulation mediated by ATG16L1 and miR-132-3p in SH-SY5Y cells treated with retinoic acid | Epileptic Disord | 2022 | 36117315 | PubTator, text mining | PubMed |
| Non-coding RNAs and epithelial mesenchymal transition in cancer: molecular mechanisms and clinical implications. | J Exp Clin Cancer Res | 2022 | 36114510 | PubTator, text mining | PubMed |
Comprehensive bioinformatics analysis to identify a novel cuproptosis-related prognostic signature and its ceRNA regulatory axis and candidate traditional Chinese medicine active ingredients in lung adenocarcinoma. | Front Pharmacol | 2022 | 36110528 | PubTator, text mining | PubMed |
| Exosomes and cancer - Diagnostic and prognostic biomarkers and therapeutic vehicle. | Oncogenesis | 2022 | 36109501 | PubTator, text mining | PubMed |
| The role of long noncoding RNAs as regulators of the epithelial-Mesenchymal transition process in oral squamous cell carcinoma cells. | Front Mol Biosci | 2022 | 36106022 | PubTator, text mining | PubMed |
| Modulating glioblastoma chemotherapy response: Evaluating long non-coding RNA effects on DNA damage response, glioma stem cell function, and hypoxic processes. | Neurooncol Adv | 2022 | 36105389 | PubTator, text mining | PubMed |
| Long noncoding RNAs as therapeutic targets to overcome chemoresistance in ovarian cancer. | Front Cell Dev Biol | 2022 | 36105363 | PubTator, text mining | PubMed |
| Integrated Analysis of the lncRNA-Associated ceRNA Network in Wilms Tumor via TARGET and GEO Databases. | Genet Res (Camb) | 2022 | 36101743 | PubTator, text mining | PubMed |
| Transcriptomic Response to Calcium in Normal Colon Organoids is Impacted by Colon Location and Sex. | Cancer Prev Res (Phila) | 2022 | 36095330 | PubTator, text mining | PubMed |
| Clinicopathological and prognostic significance of the long non-coding RNA HOTAIR high expression in head and neck squamous cell carcinoma: a systematic review and meta-analysis. | Transl Cancer Res | 2022 | 36093512 | PubTator, text mining | PubMed |
| Long non-coding RNAs: Modulators of phenotypic transformation in vascular smooth muscle cells. | Front Cardiovasc Med | 2022 | 36093159 | PubTator, text mining | PubMed |
| Biological effects and regulation of IGFBP5 in breast cancer. | Front Endocrinol (Lausanne) | 2022 | 36093095 | PubTator, text mining | PubMed |
| Elevated insulin-like growth factor 2 mRNA binding protein 1 levels predict a poor prognosis in patients with breast carcinoma using an integrated multi-omics data analysis. | Front Genet | 2022 | 36092925 | PubTator, text mining | PubMed |
| Geometric complement heterogeneous information and random forest for predicting lncRNA-disease associations. | Front Genet | 2022 | 36092871 | PubTator, text mining | PubMed |
| The history of small extracellular vesicles and their implication in cancer drug resistance. | Front Oncol | 2022 | 36091133 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/652995/papers?page=36